“Today marks a new era in spine surgery,” said Nissan Elimelech, founder and CEO, Augmedics. “This first case is just the beginning of a revolutionary change to the way surgery is performed by providing surgeons with more control, giving them the information they need, directly within their working field of sight, to instill technological confidence in the surgical workflow, and to help surgeons perform as safely and effectively as possible. We expect xvision will dramatically improve accuracy, safety, operating efficiencies and patient outcomes in an environment that increasingly can tolerate nothing less.”
On June 15, 2020, the company issued a press release announcing $15 million in Series B financing. Interestingly, the fundraising was led by the employee-formed AUG Management, LLC., which raised $4 million. The internal fundraising was led by President and Chief Commercial Officer Tim Murawski. “We are a team of problem solvers,” said Murawski. “The creativity and ingenuity of our company began when Augmedics launched to solve a problem our founder saw in the operating room, and it runs through each and every employee who is working to make the vision a success. The global pandemic presented just one more hurdle for us to navigate as a team, and we believe it has only made the company stronger.”
The xvision Spine System is currently only indicated for spine surgery, but Augmedics plans to pursue additional indications in the future. The company believes that the system’s small footprint, cost, and broad compatibility will allow integration into operating rooms nationwide.
